See What HealthDay Can Do For You
Contact Us

Soluble Interleukin 2 Receptor IDs Sarcoidosis in Uveitis

sIL-2R has slightly better diagnostic value than ACE for sarcoidosis in patients with uveitis

woman\'s face

MONDAY, Nov. 13, 2017 (HealthDay News) -- Soluble interleukin 2 receptor (sIL-2R) has slightly better diagnostic value than angiotensin-converting enzyme (ACE) for sarcoidosis in patients with uveitis, according to a study published online Nov. 9 in JAMA Ophthalmology.

Fahriye Groen-Hakan, M.D., from Erasmus University in the Netherlands, and colleagues conducted a cross-sectional retrospective study using data from 249 patients with uveitis. Measurements of sIL-2R and ACE from serum samples were determined and compared as diagnostic biomarkers of sarcoidosis.

The researchers found that patients with sarcoidosis-associated uveitis had the highest mean serum sIL-2R and ACE levels and that patients with HLA-B27-associated and varicella-zoster-virus-associated uveitis also had elevated serum sIL-2R levels. There was a significant correlation for serum sIL-2R and ACE levels but no correlation between uveitis activity and either sIL-2R or ACE. The highest Youden index was 0.45 for sIL-2R alone, corresponding to an optimal cutoff of 4,000 pg/mL and providing sensitivity and specificity of 81 and 64 percent, respectively, alone, and 92 and 58 percent, respectively, when combined with chest radiography. At a cutoff of 6,000 pg/mL, chest radiography combined with sIL-2R yielded 77 and 73 percent sensitivity and specificity. At the standard cutoff of 68U/L, combined chest radiography and serum ACE levels resulted in 70 and 79 percent sensitivity and specificity, respectively.

"This cross-sectional study demonstrates that sIL-2R is a useful marker for diagnosing sarcoidosis in patients with uveitis and has slightly better diagnostic value than ACE," the authors write.

One author disclosed ties to the pharmaceutical industry; the study was partially funded by AbbVie.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.